Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2012

01-08-2012 | Original Article

Elevated Fecal Short Chain Fatty Acid and Ammonia Concentrations in Children with Autism Spectrum Disorder

Authors: Lv Wang, Claus Thagaard Christophersen, Michael Joseph Sorich, Jacobus Petrus Gerber, Manya Therese Angley, Michael Allan Conlon

Published in: Digestive Diseases and Sciences | Issue 8/2012

Login to get access

Abstract

Background and Aim

Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder where a high frequency of gastrointestinal disturbance (e.g., constipation and diarrhea) is reported. As large bowel fermentation products can have beneficial or detrimental effects on health, these were measured in feces of children with and without ASD to examine whether there is an underlying disturbance in fermentation processes in the disorder.

Methods

Fecal samples (48 h) were collected from children with ASD (n = 23), and without ASD (n = 31) of similar age. Concentrations of short chain fatty acids, phenols and ammonia were measured.

Results

Fecal total short chain fatty acid concentrations were significantly higher in children with ASD compared to controls (136.6 ± 8.7 vs. 111.1 ± 6.6 mmol/kg). Moreover, when concentrations of fecal acetic, butyric, isobutyric, valeric, isovaleric and caproic acids were measured, all were significantly higher in children with ASD compared with controls except for caproic acid. The concentration of fecal ammonia was also significantly greater in ASD participants than controls (42.7 ± 3.3 vs. 32.3 ± 1.9 mmol/kg). Fecal phenol levels and pH did not differ between groups. Macronutrient intake, as determined from dietary records kept by caregivers, also did not differ significantly between study groups.

Conclusions

Our results suggest fermentation processes or utilization of fermentation products may be altered in children with ASD compared to children without ASD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Eapen V. Genetic basis of autism: is there a way forward? Curr Opin Psychiatr. 2011;24:226–236.CrossRef Eapen V. Genetic basis of autism: is there a way forward? Curr Opin Psychiatr. 2011;24:226–236.CrossRef
2.
go back to reference Buie T, Campbell DB, Fuchs Iii GJ, et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics. 2010;125:S1–S18.PubMedCrossRef Buie T, Campbell DB, Fuchs Iii GJ, et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics. 2010;125:S1–S18.PubMedCrossRef
3.
go back to reference Wang L, Angley MT, Gerber JP, et al. Is urinary indolyl-3-acryloylglycine a biomarker for autism with gastrointestinal symptoms? Biomarkers. 2009;14:596–603.PubMedCrossRef Wang L, Angley MT, Gerber JP, et al. Is urinary indolyl-3-acryloylglycine a biomarker for autism with gastrointestinal symptoms? Biomarkers. 2009;14:596–603.PubMedCrossRef
4.
go back to reference Campbell DB, Buie TM, Winter H, et al. Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics. 2009;123:1018–1024.PubMedCrossRef Campbell DB, Buie TM, Winter H, et al. Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics. 2009;123:1018–1024.PubMedCrossRef
5.
go back to reference Wang L, Christophersen CT, Sorich MJ, et al. Low relative abundances of the mucolytic bacterium akkermansia muciniphila and bifidobacterium spp. in feces of children with autism. Appl Environ Microbiol. 2011;77:6718–6721.PubMedCrossRef Wang L, Christophersen CT, Sorich MJ, et al. Low relative abundances of the mucolytic bacterium akkermansia muciniphila and bifidobacterium spp. in feces of children with autism. Appl Environ Microbiol. 2011;77:6718–6721.PubMedCrossRef
6.
go back to reference Finegold SM, Dowd SE, Gontcharova V, et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe. 2010;16:444–453.PubMedCrossRef Finegold SM, Dowd SE, Gontcharova V, et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe. 2010;16:444–453.PubMedCrossRef
7.
go back to reference Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001;81:1031–1064.PubMed Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001;81:1031–1064.PubMed
8.
go back to reference Nowak A, Libudzisz Z. Influence of phenol, p-cresol and indole on growth and survival of intestinal lactic acid bacteria. Anaerobe. 2006;12:80–84.PubMedCrossRef Nowak A, Libudzisz Z. Influence of phenol, p-cresol and indole on growth and survival of intestinal lactic acid bacteria. Anaerobe. 2006;12:80–84.PubMedCrossRef
9.
go back to reference Meletis CD, Zabriskie N. Supporting gastrointestinal health with nutritional therapy. Altern Complement Ther. 2008;14:132–138.CrossRef Meletis CD, Zabriskie N. Supporting gastrointestinal health with nutritional therapy. Altern Complement Ther. 2008;14:132–138.CrossRef
10.
go back to reference Williams BL, Hornig M, Buie T, et al. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS ONE. 2011;6:e24585.PubMedCrossRef Williams BL, Hornig M, Buie T, et al. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS ONE. 2011;6:e24585.PubMedCrossRef
11.
go back to reference Smith RA, Farnworth H, Wright B, Allgar V. Are there more bowel symptoms in children with autism compared to normal children and children with other developmental and neurological disorders?: a case control study. Autism. 2009;13:343–355.PubMedCrossRef Smith RA, Farnworth H, Wright B, Allgar V. Are there more bowel symptoms in children with autism compared to normal children and children with other developmental and neurological disorders?: a case control study. Autism. 2009;13:343–355.PubMedCrossRef
12.
go back to reference Chaney AL, Marbach EP. Modified reagents for determination of urea and ammonia. Clin Chem. 1962;8:130–132.PubMed Chaney AL, Marbach EP. Modified reagents for determination of urea and ammonia. Clin Chem. 1962;8:130–132.PubMed
13.
go back to reference King RA, May BL, Davies DA, Bird AR. Measurement of phenol and p-cresol in urine and feces using vacuum microdistillation and high-performance liquid chromatography. Anal Biochem. 2009;384:27–33.PubMedCrossRef King RA, May BL, Davies DA, Bird AR. Measurement of phenol and p-cresol in urine and feces using vacuum microdistillation and high-performance liquid chromatography. Anal Biochem. 2009;384:27–33.PubMedCrossRef
14.
go back to reference McOrist AL, Abell GCJ, Cooke C, Nyland K. Bacterial population dynamics and faecal short-chain fatty acid (SCFA) concentrations in healthy humans. Brit J Nutr. 2008;100:138–146.PubMedCrossRef McOrist AL, Abell GCJ, Cooke C, Nyland K. Bacterial population dynamics and faecal short-chain fatty acid (SCFA) concentrations in healthy humans. Brit J Nutr. 2008;100:138–146.PubMedCrossRef
15.
go back to reference MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, et al. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res. 2007;176:149–169.PubMedCrossRef MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, et al. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res. 2007;176:149–169.PubMedCrossRef
16.
go back to reference MacFabe DF, Rodraguez-Capote K, Hoffman JE, et al. A novel rodent model of autism: Intraventricular infusions of propionic acid increase locomotor activity and induce neuroinflammation and oxidative stress in discrete regions of adult rat brain. Am J Biochem Biotechnol. 2008;4:146–166.CrossRef MacFabe DF, Rodraguez-Capote K, Hoffman JE, et al. A novel rodent model of autism: Intraventricular infusions of propionic acid increase locomotor activity and induce neuroinflammation and oxidative stress in discrete regions of adult rat brain. Am J Biochem Biotechnol. 2008;4:146–166.CrossRef
17.
go back to reference Wong JMW, De Souza R, Kendall CWC, Emam A, Jenkins DJA. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40:235–243.PubMedCrossRef Wong JMW, De Souza R, Kendall CWC, Emam A, Jenkins DJA. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40:235–243.PubMedCrossRef
18.
go back to reference Tjellstrom B, Stenhammar L, Hogberg L, et al. Gut microflora associated characteristics in children with celiac disease. Am J Gastroenterol. 2005;100:2784–2788.PubMedCrossRef Tjellstrom B, Stenhammar L, Hogberg L, et al. Gut microflora associated characteristics in children with celiac disease. Am J Gastroenterol. 2005;100:2784–2788.PubMedCrossRef
19.
go back to reference Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474:327–336.PubMedCrossRef Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474:327–336.PubMedCrossRef
20.
go back to reference Maslowski KM, Vieira AT, Ng A, Kranich J, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461:1282–1286.PubMedCrossRef Maslowski KM, Vieira AT, Ng A, Kranich J, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461:1282–1286.PubMedCrossRef
21.
go back to reference D’Eufemia P, Celli M, Finocchiaro R, et al. Abnormal intestinal permeability in children with autism. Acta Paediatr. 1996;85:1076–1079.PubMedCrossRef D’Eufemia P, Celli M, Finocchiaro R, et al. Abnormal intestinal permeability in children with autism. Acta Paediatr. 1996;85:1076–1079.PubMedCrossRef
22.
go back to reference de Magistris L, Familiari V, Pascotto A, et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastr Nutr. 2010;51:418–424.CrossRef de Magistris L, Familiari V, Pascotto A, et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastr Nutr. 2010;51:418–424.CrossRef
23.
go back to reference Messahel S, Pheasant AE, Pall H, et al. Urinary levels of neopterin and biopterin in autism. Neurosci Lett. 1998;241:17–20.PubMedCrossRef Messahel S, Pheasant AE, Pall H, et al. Urinary levels of neopterin and biopterin in autism. Neurosci Lett. 1998;241:17–20.PubMedCrossRef
24.
go back to reference van Nuenen MH, Venema K, van der Woude JC, Kuipers EJ. The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease. Dig Dis Sci. 2004;49:485–491.PubMedCrossRef van Nuenen MH, Venema K, van der Woude JC, Kuipers EJ. The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease. Dig Dis Sci. 2004;49:485–491.PubMedCrossRef
25.
go back to reference Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA. Gastrointestinal flora and gastrointestinal status in children with autism—comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 2011;11:22.PubMedCrossRef Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA. Gastrointestinal flora and gastrointestinal status in children with autism—comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 2011;11:22.PubMedCrossRef
26.
go back to reference Clark-Taylor T, Clark-Taylor BE. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial [beta]-oxidation by long chain acyl-CoA dehydrogenase. Med Hypotheses. 2004;62:970–975.PubMedCrossRef Clark-Taylor T, Clark-Taylor BE. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial [beta]-oxidation by long chain acyl-CoA dehydrogenase. Med Hypotheses. 2004;62:970–975.PubMedCrossRef
27.
go back to reference Filipek PA, Juranek J, Nguyen MT, Cummings C, Gargus JJ. Relative carnitine deficiency in autism. J Autism Dev Disord. 2004;34:615–623.PubMedCrossRef Filipek PA, Juranek J, Nguyen MT, Cummings C, Gargus JJ. Relative carnitine deficiency in autism. J Autism Dev Disord. 2004;34:615–623.PubMedCrossRef
29.
go back to reference Altieri L, Neri C, Sacco R, et al. Urinary p-cresol is elevated in small children with severe autism spectrum disorder. Biomarkers. 2011;16:9.CrossRef Altieri L, Neri C, Sacco R, et al. Urinary p-cresol is elevated in small children with severe autism spectrum disorder. Biomarkers. 2011;16:9.CrossRef
30.
go back to reference Yap IK, Angley M, Veselkov KA, et al. Urinary metabolic phenotyping differentiates children with autism, from their unaffected siblings and age-matched controls. J Proteome Res. 2010;9:2996–3004.PubMedCrossRef Yap IK, Angley M, Veselkov KA, et al. Urinary metabolic phenotyping differentiates children with autism, from their unaffected siblings and age-matched controls. J Proteome Res. 2010;9:2996–3004.PubMedCrossRef
31.
go back to reference Clayton TA, Baker D, Lindon JC, Everett JR, Nicholson JK. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA. 2009;106:14728–14733.PubMedCrossRef Clayton TA, Baker D, Lindon JC, Everett JR, Nicholson JK. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA. 2009;106:14728–14733.PubMedCrossRef
32.
go back to reference Birkett AM, Jones GP, de Silva AM, Young GP, Muir JG. Dietary intake and faecal excretion of carbohydrate by Australians: importance of achieving stool weights greater than 150 g to improve faecal markers relevant to colon cancer risk. Euro J Clin Nutr. 1997;51:625–632.CrossRef Birkett AM, Jones GP, de Silva AM, Young GP, Muir JG. Dietary intake and faecal excretion of carbohydrate by Australians: importance of achieving stool weights greater than 150 g to improve faecal markers relevant to colon cancer risk. Euro J Clin Nutr. 1997;51:625–632.CrossRef
33.
go back to reference Hopkins MJ, Sharp R, Macfarlane GT. Variation in human intestinal microbiota with age. Dig Liver Dis. 2002;34:S12–S18.PubMedCrossRef Hopkins MJ, Sharp R, Macfarlane GT. Variation in human intestinal microbiota with age. Dig Liver Dis. 2002;34:S12–S18.PubMedCrossRef
34.
go back to reference Whiteley P, Todd L, Carr K, Shattock P. Gender ratios in autism, Asperger syndrome and autism spectrum disorder. Autism Insights. 2010;2:17–24.CrossRef Whiteley P, Todd L, Carr K, Shattock P. Gender ratios in autism, Asperger syndrome and autism spectrum disorder. Autism Insights. 2010;2:17–24.CrossRef
35.
go back to reference McOrist AL, Miller RB, Bird AR, et al. Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch. J Nutr. 2011;141:883–889.PubMedCrossRef McOrist AL, Miller RB, Bird AR, et al. Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch. J Nutr. 2011;141:883–889.PubMedCrossRef
36.
go back to reference Bird AR, Conlon MA, Christophersen CT, Topping DL. Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics. Benef Microbes. 2010;1:423–431.PubMedCrossRef Bird AR, Conlon MA, Christophersen CT, Topping DL. Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics. Benef Microbes. 2010;1:423–431.PubMedCrossRef
37.
go back to reference Fukuda S, Toh H, Hase K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469:543–547.PubMedCrossRef Fukuda S, Toh H, Hase K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469:543–547.PubMedCrossRef
Metadata
Title
Elevated Fecal Short Chain Fatty Acid and Ammonia Concentrations in Children with Autism Spectrum Disorder
Authors
Lv Wang
Claus Thagaard Christophersen
Michael Joseph Sorich
Jacobus Petrus Gerber
Manya Therese Angley
Michael Allan Conlon
Publication date
01-08-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2167-7

Other articles of this Issue 8/2012

Digestive Diseases and Sciences 8/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine